Bisoprolol Initiation and Titration in Heart Failure with Reduced Ejection Fraction
Start bisoprolol at 1.25 mg once daily in stable HFrEF patients already on ACE inhibitor therapy, then double the dose every 1-2 weeks as tolerated until reaching the target dose of 10 mg once daily. 1, 2
Pre-Initiation Requirements
Before starting bisoprolol, ensure the patient meets these criteria 3, 1:
- Background therapy: Patient must be on ACE inhibitor (or ARB if ACE-intolerant) unless contraindicated
- Clinical stability: No intravenous inotropic support needed, no marked fluid retention, no recent hospitalization for worsening HF within past 4 weeks
- Baseline parameters: Heart rate ≥50 bpm, no second- or third-degree heart block without pacemaker
Dosing Schedule
The evidence-based titration protocol from landmark trials 1:
| Week | Bisoprolol Dose |
|---|---|
| 0-2 | 1.25 mg once daily |
| 2-4 | 2.5 mg once daily |
| 4-6 | 3.75 mg once daily |
| 6-8 | 5 mg once daily |
| 8-10 | 7.5 mg once daily |
| 10+ | 10 mg once daily (target) |
Double the dose every 1-2 weeks if the preceding dose was well tolerated. Most patients can be managed as outpatients during titration. 1
Monitoring During Titration
At each visit before dose escalation, assess 3, 1:
- Heart rate: Hold uptitration if <50 bpm with worsening symptoms
- Blood pressure: Monitor for symptomatic hypotension (dizziness, lightheadedness)
- Fluid status: Check for signs of congestion (raised JVP, peripheral edema, weight gain)
- Symptoms: Assess for increased dyspnea, fatigue, or functional decline
Check blood chemistry 1-2 weeks after initiation and 1-2 weeks after reaching final dose. 3
Problem-Solving During Titration
Worsening Heart Failure Symptoms
First increase diuretic dose rather than reducing beta-blocker. Only halve the bisoprolol dose if increasing diuretics doesn't work. 3, 1 Advise patients to weigh themselves daily and increase diuretic dose if weight increases by 1.5-2.0 kg over 2 days. 3
Symptomatic Hypotension
First reduce vasodilator doses (nitrates, hydralazine) before reducing bisoprolol. Maintain ACE inhibitor if possible. 1 Asymptomatic hypotension does not require intervention. 2
Bradycardia (<50 bpm with symptoms)
- Review and reduce/discontinue other heart rate-lowering drugs (digoxin, amiodarone, diltiazem)
- Obtain ECG to exclude heart block
- Halve bisoprolol dose only if necessary; discontinue only if clearly required
- Seek specialist advice 3, 1
Marked Fatigue
Temporarily halve the dose if severe, but always attempt reintroduction and uptitration when patient stabilizes. 1
Special Populations
Renal or hepatic impairment (creatinine clearance <40 mL/min, hepatitis, cirrhosis): Start at 1.25 mg daily with slower titration. 4 Bisoprolol is not dialyzable, so no dose adjustment needed for dialysis patients.
Elderly patients: No dose adjustment needed unless significant renal/hepatic dysfunction present. 4
Recently decompensated patients: Cautious pre-discharge initiation is possible if patient has improved with other treatments, is not dependent on IV inotropes, and can be observed in hospital for at least 24 hours after initiation. 2
Absolute Contraindications 2, 5
- Asthma (COPD is NOT a contraindication)
- Second- or third-degree heart block without pacemaker
- Sick sinus syndrome without pacemaker
- Sinus bradycardia <50 bpm
Patients Requiring Specialist Referral 3, 1
- NYHA class IV severe heart failure
- Unknown etiology of cardiomyopathy
- Relative contraindications: asymptomatic bradycardia, low blood pressure
- Intolerance to low doses
- Previous beta-blocker discontinuation due to symptoms
- Suspected bronchial asthma or severe pulmonary disease
Critical Clinical Pearls
Some beta-blocker is better than no beta-blocker. 3 If target dose cannot be achieved, maintain the maximum tolerated dose rather than discontinuing therapy.
Temporary symptomatic deterioration occurs in 20-30% of patients during initiation/uptitration. 3 Counsel patients that symptomatic improvement may take 3-6 months or longer, and that treatment prevents disease progression even if symptoms don't immediately improve.
Never abruptly discontinue bisoprolol in patients with coronary artery disease due to risk of exacerbating angina, myocardial infarction, or ventricular arrhythmia. 4 If withdrawal is necessary, taper over approximately one week under careful observation.
In hospitalized patients with worsening HF, dose reduction may be necessary, but reinstitute and uptitrate as soon as clinically stable, preferably before discharge. 2